Difference between revisions of "Part:BBa K2065007"

Revision as of 00:21, 19 October 2016

CT52-LargeBiT

The CT52-LargeBiT BioBrick is part of a split luciferase system. This luciferase system consists of two parts, namely SmallBiT and LargeBiT. It is a ATP-independent luciferase, that produces high intensity luminescence. The total weight of LargeBiT-CT52 is 25.8 kDa. The NanoLuc system consists of 171 amino acids. When they dimerize, this means when they come into close proximity of each other, a substrate can create bioluminescence . The emission peak of this NanoBiT system is around 460 nanometers. The CT52 part of this BioBrick has affinity for the T14-3-3 scaffold protein. The binding between CT52 and T14-3-3 is mediated by the small molecule fusicoccin. Together with CT52-SmallBiT"https://parts.igem.org/Part:BBa_K2065000" this BioBrick is used in testing the quality of T14-3-3 heterodimers.

Usage and Biology

LargeBiT is linked to CT52 with a GGS10-linker, so it actually consists of three subparts. LargeBiT is 477 basepairs long and thus consists of 159 amino acids. The GGS10-linker that is used, consists of 30 amino acids, it is a ten-times repeated sequence of Glycine-Glycine-Serine amino acids. This complex is linked to CT52. This protein consist of the last 52 amino acids of the C-terminal region of the H+-ATPase. The N-terminus of CT52 is a free end, which can be used to link proteins to. The binding between CT52 and T14-3-3 is stabilized by the small molecule Fusicoccin. When Fusicoccin is present, the affinity of CT52 for T14-3-3 is increased in 30 fold with respect to the situation when Fusicoccin is not present [1]. The binding interaction with Fusicoccin is reversibel, this means CT52 will dissociate from the scaffold.

This means that the CT52-GGS10-LargeBiT construct will move towards the scaffold protein, after a small molecule, Fusicoccin, is added. Three different variants of the CT52-protein were created with the help of the Rosetta software package. Each mutation in the CT52 protein has its complementary mutation in the T14-3-3 protein. Because these mutations were found with the help of the Rosetta software package, the quality of these mutations have to be verified. One variant of the CT52 protein was already known and tested. This mutation functioned as a positive control in the verification process of the other mutations.

Sequence

The sequence of our CT52-LargeBiT has been verified by StarSeq. It contains the prefix and suffix with the correct restriction sites (EcoRI, XbaI, SpeI and PstI). CT52-GGS10-LargeBiT is 723 basepairs long.

Sequence and Features

Bioluminescence confirmation

To determine whether the split luciferase system is working, a bioluminescence signal should be visible when the two components come into close proximity of each other. A bioluminescence peak around 460nm must be visible when SmallBiT and LargeBiT dimerize.When the two NanoBiTs are into close proximity of each other, they dimerize. When Furimazine is added to the dimerized Nanoluc luciferase, the Furimazine is converted into Furimamide. When this reaction occurs, light with a wavelength of 460 nm will be emitted. The spectrum of the CT52-NanoBiT system is visualed below.
Figure 2: Bioluminescence spectrum with CT52(I947H)-LargeBiT and CT52-SmallBiT, assembled on T14-3-3(S71L) - T14-3-3

An example of a measurement which can be done on a heterodimer is a T14-3-3 heterodimer concentration gradient assay, in which the functionality can be verified. This measurement is shown below for T14-3-3(S71L) - T14-3-3
Figure 3: T14-3-3 functionality measurement with varying scaffold concentrations from 0 nM to 1 µM T14-3-3(S71L/I72V)-T14-3-3. 50 µM fusicoccin was used for all measurements. Mutant forms CT52 (I947F)-LargeBiT and CT52(wildtype)-SmallBiT were used with a concentration of 200 nM. The substrate used was 1250x diluted from stock.

CT52-LargeBiT statistics